Third Pole Therapeutics

Heart and Lung Therapy Reimagined Navigation
  • About Us
    • Our History
    • Our Team
    • Our Board of Directors
    • Our Scientific Advisors
    • Company Press Releases
    • Our Policies
  • Technology
  • Products
  • Partnering
  • News and Publications
  • Careers
  • Contact Us
  • About Us
    • Our History
    • Our Team
    • Our Board of Directors
    • Our Scientific Advisors
    • Company Press Releases
    • Our Policies
  • Technology
  • Products
  • Partnering
  • News and Publications
  • Careers
  • Contact Us
  • Heart and Lung Therapy
    Reimagined
    Making Life-saving Benefits of Inhaled Nitric Oxide
    Accessible… On Demand… Anywhere in the World
    LEARN MORE

Latest News & Publications

  • Third Pole Therapeutics – eNOfit – First Wearable Drug Making PlatformJanuary 6, 2022
  • 200 Years of Patient Care. Patient Pioneer: The Story of Courtney JoyceOctober 27, 2021
  • Can Nitric Oxide Prevent COVID-19 Infection or Progression?May 28, 2020
  • How a discovery that brought us Viagra could help those battling the coronavirusMay 1, 2020
  • How the gas that gave the world Viagra could help treat coronavirus patientsMay 1, 2020
All News & Publications

Latest Press Releases

  • Third Pole Therapeutics Receives $32M Strategic Equity Investment to Accelerate its Tankless Inhaled Nitric Oxide (iNO) PlatformDecember 14, 2022
  • Third Pole Therapeutics Closes $25M Financing – eNOfit™ Wearable Device Now Ready for Clinical TrialsFebruary 3, 2022
  • Third Pole Therapeutics to Participate in H.C. Wainwright BioConnect and BIO Partnering at JPM during J.P. Morgan 40th Annual Healthcare ConferenceJanuary 6, 2022
  • Third Pole Therapeutics Secures $15 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.April 15, 2021
  • Third Pole Therapeutics Expands Board of DirectorsFebruary 24, 2021

All Press Releases

  • Home
  • About Us
  • Technology
  • Products
  • Partnering
  • News and Publications
  • Careers
  • Contact Us

© 2017-2019 Third Pole, Inc.